Form D · Other
BIOBEATS, INC.
Vancouver, A1 · CIK 0001613957
Offering snapshot reported Jul 16, 2014 · SEC filing
- Reported sold
- $299K Offering amount: $751K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 27, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 16, 2014 | Initial | $299,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-221229
This filing covers the issuance of Series Seed Preferred Shares and the underlying Common Stock issuable upon conversion thereof.
Source: Form D, filed Jul 16, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Plans Casal | Director, Executive |
| Davide Morelli | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1040 West Georgia Street Suite 950
Vancouver, A1, V6E 4H1
Vancouver, A1, V6E 4H1